Hui L. Ding
Lanzhou, 730030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Double-negative prostate cancer: Evolutionary mechanisms, microenvironmental remodeling, and clinical translation.
Journal: Critical reviews in oncology/hematology
Published: May 23, 2026
Efficacy and safety of triple or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis.
Journal: Future oncology (London, England)
Published: February 16, 2026
Pyrene trisulfonic acid-functionalized silica-based multi-mode stationary phase for separation of hydrophilic, hydrophobic compounds and rare earth ions.
Journal: Analytica chimica acta
Published: December 25, 2025
The efficacy and safety of adrenergic alpha-antagonists combined with PDE5 inhibitors in the medical expulsive therapy for unilateral distal ureteral stones: a systematic review and meta-analysis.
Journal: Translational andrology and urology
Published: December 21, 2025
Anastomosing hemangioma of the kidney: a case report.
Journal: Frontiers in oncology
Published: December 14, 2025
Brain metastasis from prostate cancer with neurologic symptoms as the first sign: a case report.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: November 26, 2025
The safety and effectiveness of hypofractionated radiotherapy for localized prostate cancer: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: November 09, 2025
Targeting EGFR with sanguinarine chloride: a novel approach to bladder cancer therapy.
Journal: Biochemical pharmacology
Published: July 17, 2025
Renal pelvic pressure drives fluid absorption in mini-percutaneous nephrolithotomy: a quantitative model for absorption rate.
Journal: BJU international
Published: June 08, 2025
TAK-901 targeted inhibition of EGFR activates transcription factor FOXO causing cell cycle arrest and apoptosis in bladder cancer.
Journal: Molecular cancer therapeutics
Published: May 07, 2025
TAK-901 Targeted Inhibition of EGFR Activates Transcription Factor FOXO, Causing Cell-cycle Arrest and Apoptosis in Bladder Cancer.
Journal: Molecular cancer therapeutics
Published: May 07, 2025
Last Updated: 09/26/2026